Cole Mercer

I find the trade before it's obvious. Long-term capital allocator. NFA DYOR. 15+ years and counting. Don’t get rich…get wealthy.

[Cole Mercer @ColeMInvests]

$ORCL touched $175 this morning and bounced. That’s the exact 0.618 Fibonacci retracement of the $135 to $245 move. Technical support held. Down 8.5% on the day but the level that mattered held.

[Cole Mercer @ColeMInvests]

$GRRR up 13% today. Called the golden cross setup this morning after the convertible note selloff. 50 DMA, 200 DMA, 0.618 Fib all at the same level. Still watching $22.50.

[Drug Money Capital ™️ @TheDrugMoney]

$HIMS bought a peptide manufacturing facility in February 2025.

Longevity product line launching this year.

On July 23 the FDA votes on officially reclassifying 7 peptides to Category 1.

$HIMS at $27 is still trading 18% below its 200 day.

The catalysts are stacking.

[Cole Mercer @ColeMInvests]

Now sitting at the exact 0.618 Fib retracement at $177. Hold this level and this is a buyable overreaction. Lose it and the next support is $158, then $135. The business didn’t change today, just the valuation.

[Cole Mercer @ColeMInvests]

$ORCL beat the quarter and dropped 12%. The market doesn’t care about the earnings…it cares about the $40B capital raise. Dilution fear beats earnings beats right now.

[Cole Mercer @ColeMInvests]

$GRRR sold off 12% on the convertible note offering. That shakeout happened right at the golden cross. 50 DMA, 200 DMA, and 0.618 Fib all at the same level. Now up 9% on the day. Still watching $22.50.

[Cole Mercer @ColeMInvests]

$BB quietly pushing toward $10. Earnings on June 25. QNX software is running in hundreds of millions of vehicles and the market barely prices it in. That changes at some point.

[Cole Mercer @ColeMInvests]

$THC up 3.4% while tech is mixed. Tenet Healthcare is near its 52 week lows. Real earnings, real cash flow. When the AI names get choppy you should start looking at names like this.

[Cole Mercer @ColeMInvests]

SpaceX IPO is lifting the whole space sector but $ASTS doesn’t need that story. They already have satellites in orbit and a real network building. Up 5% today at $91. 52 week high is $133. The gap still exists.

[Cole Mercer @ColeMInvests]

$NBIS retesting Wave 4 support at $200 right now. Stock ran from $77 to $280 this year, pulled all the way back and held the level. Wave 5 target is $400+. AI neocloud with revenue up 684% last quarter.

[Cole Mercer @ColeMInvests]

$GRRR held green yesterday when $NVDA dropped nearly 4%. Pre-market up another 3% to $16.62. This one sets up for $22 in the short to mid term.

[Cole Mercer @ColeMInvests]

$ZETA got hit 5.5% yesterday, barely bouncing pre-market. $20 has to hold on the open. Still a $34 Wave 3 target but need to see buyers step in first.

[Cole Mercer @ColeMInvests]

$49B in free cash flow last quarter. Forward P/E of 22x on 85% revenue growth. PEG of 0.47. Multi-day selloff hands you the best business in tech at half its growth rate. The business hasn’t changed

[Cole Mercer @ColeMInvests]

$NVDA closed at $200…thats not a coincidence. It’s the 38.2% retracement of the entire 52-week rally AND the 50% retracement of the last leg up, with both pointing at the same level. Either it holds here or the next stop is $188.

[Zarie @zarieinvests]

Healthcare stocks will go on a major bull run soon!

[Cole Mercer @ColeMInvests]

$ZETA is a legit 5-10x opportunity. Prepare accordingly.

[Cole Mercer @ColeMInvests]

Honestly probably $BB. I feel like the value of their QNX OS alone is worth more than the market cap of the entire company.

[Drug Money Capital ™️ @TheDrugMoney]

What public company has the best product relative to its stock price right now?

[Cole Mercer @ColeMInvests]

$PLTR basically flat on one of the uglier days of the year. That’s the kind of relative strength that builds into the next leg up.

[Cole Mercer @ColeMInvests]

$GRRR tested $15.56 this morning and bounced. Sitting at $16.45 now. That’s the level that mattered. Wave 4 holding so far.

[Cole Mercer @ColeMInvests]

$ORCL reports after close today. $553B RPO. 84% cloud growth last quarter. Everyone’s watching EPS. I’m watching guidance.